Bridger M W, Beale F A, Bryce D P
J Otolaryngol. 1978 Oct;7(5):379-88.
One hundred and fifty-eight cases of paranasal sinus cancer have been reviewed retrospectively. The actuarial survival at five years for the whole group was 33%. The American Joint Committee (AJC) classification for maxillary cancer was used. T1 and T2 cases, with an actuarial survival of 44% at five years, had a significantly better prognosis than T3 cases (31%) and T4 cases (10%). Anemia of presentation and the presence of persistent disease when surgery followed pre-operative irradiation were poor prognostic indicators. The policy of combined pre-operative irradiation followed by surgery is advocated; patients with anemia should have this corrected before and during treatment.
对158例鼻窦癌患者进行了回顾性研究。全组患者的5年精算生存率为33%。采用了美国联合委员会（AJC）对上颌窦癌的分类方法。T1和T2期患者的5年精算生存率为44%，其预后明显好于T3期患者（31%）和T4期患者（10%）。就诊时贫血以及术前放疗后手术时存在持续性疾病是预后不良的指标。提倡术前放疗联合手术的治疗策略；贫血患者在治疗前和治疗期间应纠正贫血。
